{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:12:56Z","timestamp":1793502776221,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.rmed.2023.107327","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T11:27:51Z","timestamp":1686396471000},"page":"107327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Approach to non-type 2 asthma"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5553-6182","authenticated-orcid":false,"given":"Muhammad","family":"Adrish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Akuthota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2023.107327_bib1","first-page":"S1","volume":"26","year":"2022","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"7933","key":"10.1016\/j.rmed.2023.107327_bib2","first-page":"469","article-title":"Inhaled corticosteroids compared with oral prednisone in patients starting long-term corticosteroid therapy for asthma. A controlled trial by the British Thoracic and Tuberculosis Association","volume":"2","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2023.107327_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bmj.1.5800.585","article-title":"PAPERS and originals beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma","volume":"1","author":"Morrow Brown","year":"1972","journal-title":"Br. Med. J."},{"issue":"6","key":"10.1016\/j.rmed.2023.107327_bib4","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4049\/jimmunol.146.6.1829","article-title":"T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma","volume":"146","author":"Walker","year":"1991","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2023.107327_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2023.107327_bib6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/ajrccm.154.5.8912771","article-title":"IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against \u201cintrinsic\u201d asthma being a distinct immunopathologic entity","volume":"154","author":"Humbert","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2023.107327_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/CCRPM.S7793","article-title":"Omalizumab: clinical use for the management of asthma","volume":"6","author":"Thomson","year":"2012","journal-title":"Clin. Med. Insights Circulatory, Respir. Pulm. Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaci.2013.07.036","article-title":"Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma","volume":"133","author":"Peters","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma--present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2023.107327_bib11","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaip.2020.10.035","article-title":"The relationship of asthma biologics to remission for asthma","volume":"9","author":"Menzies-Gow","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.anai.2022.04.020","article-title":"T2-low: what do we know? Annals of Allergy","volume":"129","author":"Niessen","year":"2022","journal-title":"Asthma & Immunology"},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1183\/23120541.00309-2020","article-title":"Identification and treatment of T2-low asthma in the era of biologics","volume":"7","author":"Kyriakopoulos","year":"2021","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00528-2020","article-title":"Treatment options in type-2 low asthma","volume":"57","author":"Hinks","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2016.10.034","article-title":"Identification of IL-17F\/frequent exacerbator endotype in asthma","volume":"140","author":"Ricciardolo","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2023.107327_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00068-2019","article-title":"Elevated serum IgE, oral corticosteroid dependence and IL-17\/22 expression in highly neutrophilic asthma","volume":"54","author":"Bullone","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jpm12010010","article-title":"Which therapy for non-type(T)2\/T2-Low asthma","volume":"12","author":"Ricciardolo","year":"2021","journal-title":"J. Personalized Med."},{"issue":"3","key":"10.1016\/j.rmed.2023.107327_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.chest.2021.04.013","article-title":"Eosinophilic and noneosinophilic asthma","volume":"160","author":"Heaney","year":"2021","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.rmed.2023.107327_bib19","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.jaip.2021.02.059","article-title":"Cluster analysis of inflammatory biomarker expression in the international severe asthma Registry","volume":"9","author":"Denton","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2023.107327_bib20","doi-asserted-by":"crossref","unstructured":"Uddin M, Nong G, Ward J, et al. Prosurvival Activity for Airway Neutrophils in Severe Asthma. doi:10.1136\/thx.2009.120741.","DOI":"10.1136\/thx.2009.120741"},{"key":"10.1016\/j.rmed.2023.107327_bib21","doi-asserted-by":"crossref","unstructured":"Rosales C. Neutrophils at the Crossroads of Innate and Adaptive Immunity. doi:10.1002\/JLB.4MIR0220-574RR.","DOI":"10.1002\/JLB.4MIR0220-574RR"},{"key":"10.1016\/j.rmed.2023.107327_bib22","first-page":"dyac173","article-title":"Asthma inflammatory phenotypes on four continents: most asthma is non-eosinophilic [published online ahead of print, 2022 Aug 30]","author":"Pembrey","year":"2022","journal-title":"Int. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.rmed.2023.107327_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/thoraxjnl-2020-215986","article-title":"Neutrophils in asthma: the good, the bad and the bacteria [published online ahead of print, 2021 Feb 25]","volume":"76","author":"Crisford","year":"2021","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2023.107327_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1025590308147","article-title":"Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action","volume":"8","author":"Druilhe","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.rmed.2023.107327_bib25","doi-asserted-by":"crossref","unstructured":"Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor R. Effects of Steroid Therapy on Inflammatory Cell Subtypes in Asthma. doi:10.1136\/thx.2009.126722.","DOI":"10.1136\/thx.2009.126722"},{"key":"10.1016\/j.rmed.2023.107327_bib26","volume":"vol. 12","author":"Saffar","year":"2011"},{"issue":"4","key":"10.1016\/j.rmed.2023.107327_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.alit.2017.02.016","article-title":"Airway inflammation phenotype prediction in asthma patients using lung sound analysis with fractional exhaled nitric oxide","volume":"66","author":"Shimoda","year":"2017","journal-title":"Allergol. Int."},{"key":"10.1016\/j.rmed.2023.107327_bib28","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/thx.2006.073429","article-title":"Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma","volume":"62","author":"Berry","year":"2007","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.rmed.2004.06.007","article-title":"Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma","volume":"99","author":"Nguyen","year":"2005","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MCP.0000000000000342","article-title":"T2-low asthma: current approach to diagnosis and therapy","volume":"23","author":"Samitas","year":"2017","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/all.13985","article-title":"Mechanisms and therapeutic strategies for non-T2 asthma","volume":"75","author":"Sze","year":"2020","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.rmed.2023.107327_bib32","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3390\/diagnostics12051175","article-title":"Neutrophils and asthma","volume":"12","author":"Yamasaki","year":"2022","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.rmed.2023.107327_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.coph.2007.03.001","article-title":"TNF-alpha in asthma","volume":"7","author":"Berry","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"issue":"10","key":"10.1016\/j.rmed.2023.107327_bib34","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/crj.13407","article-title":"Mechanisms and biomarkers of airway epithelial cell damage in asthma: a review","volume":"15","author":"Yang","year":"2021","journal-title":"Clin. Res. J"},{"issue":"8","key":"10.1016\/j.rmed.2023.107327_bib35","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/all.14421","article-title":"Epithelial cell dysfunction, a major driver of asthma development","volume":"75","author":"Heijink","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2023.107327_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pupt.2018.04.002","article-title":"Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells","volume":"50","author":"van den Berge","year":"2018","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2023.107327_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9230234","article-title":"Neutrophilic asthma is associated with increased airway bacterial burden and disordered community composition","volume":"2018","author":"Yang","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"10","key":"10.1016\/j.rmed.2023.107327_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002244","article-title":"Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease","volume":"7","author":"Essilfie","year":"2011","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12931-020-01438-5","article-title":"The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma","volume":"21","author":"Zhang","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2023.107327_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2018.11.016","article-title":"Microbiota and asthma: clinical implications","volume":"146","author":"Katsoulis","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2023.107327_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/642503","article-title":"Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with Noncystic fibrosis bronchiectasis","volume":"2015","author":"Dente","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.rmed.2023.107327_bib42","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/crj.12653","article-title":"Investigation of bronchiectasis in severe uncontrolled asthma","volume":"12","author":"Dimakou","year":"2018","journal-title":"Clin. Res. J"},{"key":"10.1016\/j.rmed.2023.107327_bib43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/thx.2010.157719","article-title":"Systemic upregulation of neutrophil \u03b1-defensins and serine proteases in neutrophilic asthma","volume":"66","author":"Baines","year":"2011","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/17476348.2017.1268919","article-title":"Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations","volume":"11","author":"Chang","year":"2017","journal-title":"Expet Rev. Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2023.107327_bib45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaci.2020.08.011","article-title":"Obesity and asthma","volume":"146","author":"Miethe","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2023.107327_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00125-015-3810-6","article-title":"Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes","volume":"59","author":"Acosta","year":"2016","journal-title":"Diabetologia"},{"issue":"1\u20132","key":"10.1016\/j.rmed.2023.107327_bib47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2014.12.011","article-title":"Activated type 2 innate lymphoid cells regulate beige fat biogenesis","volume":"160","author":"Lee","year":"2015","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.rmed.2023.107327_bib48","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.rmed.2023.107327_bib49","doi-asserted-by":"crossref","unstructured":"Kimura A, Kishimoto T. IL-6: Regulator of Treg\/Th17 Balance. doi:10.1002\/eji.201040391.","DOI":"10.1002\/eji.201040391"},{"issue":"6","key":"10.1016\/j.rmed.2023.107327_bib50","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1378\/chest.14-2689","article-title":"Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma","volume":"147","author":"McGarry","year":"2015","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2023.107327_bib51","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue","volume":"112","author":"Wellen","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.rmed.2023.107327_bib52","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1164\/rccm.202112-2745OC","article-title":"The impact of insulin resistance on loss of lung function and response to treatment in asthma","volume":"206","author":"Peters","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2023.107327_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coi.2020.10.002","article-title":"Mechanisms of non-type 2 asthma","volume":"66","author":"Hudey","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.rmed.2023.107327_bib54","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1096\/fj.202000170R","article-title":"Cholinergic neuroplasticity in asthma driven by TrkB signaling | nick H. T. Ten Hacken 2,4 | Wim Timens 2,7","volume":"34","author":"Dragunas","year":"2020","journal-title":"Faseb. J."},{"issue":"6","key":"10.1016\/j.rmed.2023.107327_bib55","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1165\/rcmb.2015-0015OC","article-title":"Brain-derived neurotrophic factor expression in asthma. Association with severity and type 2 inflammatory processes","volume":"53","author":"Watanabe","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jaci.2017.08.015","article-title":"Orosomucoid-like 3 (ORMDL3) upregulates airway smooth muscle proliferation, contraction, and Ca2+ oscillations in asthma","volume":"142","author":"Chen","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2023.107327_bib57","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.4049\/jimmunol.1303047","article-title":"ORMDL3 transgenic mice have increased airway remodeling and airway responsiveness characteristic of asthma","volume":"192","author":"Miller","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.rmed.2023.107327_bib58","series-title":"Advances and Highlights in Asthma in 2021","author":"Agache","year":"2021"},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib59","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1183\/09031936.00115212","article-title":"Increased glutaredoxin-1 and decreased protein S-glutathionylation in sputum of asthmatics","volume":"41","author":"Kuipers","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2023.107327_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102095","article-title":"The immunomodulatory effects of macrolide antibiotics in respiratory disease","volume":"71","author":"Pollock","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"10095","key":"10.1016\/j.rmed.2023.107327_bib61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2023.107327_bib62","unstructured":"Global Initiative for Asthma. Difficult-to-Treat and severe asthma in adults and adolescents. In: Global Strategy for Asthma Management and Prevention.Https:\/\/Ginasthma.Org\/Reports."},{"issue":"7","key":"10.1016\/j.rmed.2023.107327_bib63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/thoraxjnl-2020-216331","article-title":"Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy","volume":"76","author":"Shukla","year":"2021","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.rmed.2023.107327_bib64","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.chest.2022.02.025","article-title":"Azithromycin for poorly controlled asthma in children","volume":"161","author":"Ghimire","year":"2022","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2023.107327_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-Term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2023.107327_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051062","article-title":"Inhaled antibiotic therapy in chronic respiratory diseases","volume":"18","author":"Maselli","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2023.107327_bib67","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J. Asthma Allergy"},{"issue":"19","key":"10.1016\/j.rmed.2023.107327_bib68","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.rmed.2023.107327_bib69","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","article-title":"KIT inhibition by imatinib in patients with severe refractory asthma","volume":"376","author":"Cahill","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2023.107327_bib70","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaci.2021.10.035","article-title":"The precision interventions for severe and\/or exacerbation-prone (PrecISE) asthma network: an overview of network organization, procedures, and interventions","volume":"149","author":"Georas","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2023.107327_bib71","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaci.2019.08.031","article-title":"Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma","volume":"145","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.rmed.2023.107327_bib72","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"163","key":"10.1016\/j.rmed.2023.107327_bib73","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0241-2021","article-title":"Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy","volume":"31","author":"Keir","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2023.107327_bib74","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cpt.1053","article-title":"Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects","volume":"104","author":"Palm\u00e9r","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2023.107327_bib75","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123002159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611123002159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:16:13Z","timestamp":1762337773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611123002159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":75,"alternative-id":["S0954611123002159"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107327","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to non-type 2 asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2023.107327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107327"}}